Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinomaHyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.Experimental & Molecular Medicine|May 8, 2026
Machine learning-based integration of transcriptome and digital pathology for predicting chemoresistance in muscle-invasive bladder cancerJinahn Jeong, Gowun Jeong, YongHwan Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract CancerYeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, et al.Cancer Research and Treatment|October 14, 2025
Real World Efficacy of 1st-Line Nivolumab Plus Ipilimumab and its Practical Predictive Biomarkers in Advanced Renal Cell Carcinoma: First Analysis from RENOIR Study (KCSG GU22-13)Jwa Hoon Kim, Sang Joon Shin, Woo Kyun Bae, et al.Cancer Research and Treatment|December 14, 2021
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.Journal of Hepatology|August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinomaHyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.Journal of Cancer Research and Clinical Oncology|March 28, 2022
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimenSeung-Hoon Beom, Jong Gwang Kim, Seung Hyuk Baik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study (BRISK; KCSG AL22-16)Hyehyun Jeong, Changhoon Yoo, Shinkyo Yoon, et al.The Korean Journal of Internal Medicine|February 9, 2021
2020 Korean guidelines for the management of metastatic prostate cancerIn-Ho Kim, Sang Joon Shin, Byung Woog Kang, et al.Journal of Pathology and Translational Medicine|July 19, 2024
Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSPMiso Kim, Hyo Sup Shim, Sheehyun Kim, et al.Pageof 11